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TLR2 deficiency by compromising p19 (IL-23) expression limits T 1 
helper 17 cell responses to Mycobacterium tuberculosis. 2 
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Abstract 26 
CD4
+
 T helper 1 (Th1) cells producing IFN- are of extreme importance in controlling 27 
infections by Mycobacterium tuberculosis both in mice and men. In addition to IFN--28 
producing T cells, IL-17-producing T cells (Th17) have been observed during mycobacterial 29 
infections. Nevertheless, their contribution for the host immune response to mycobacteria, as 30 
well as the signals triggering M. tuberculosis-specific Th17 cell differentiation and 31 
maintenance are not fully understood. We show that signalling via toll-like receptor (TLR)2 32 
has a major impact on the regulation of p19 (IL-23) expression in response to M. tuberculosis, 33 
and therefore on the establishment of Th17 cell responses to M. tuberculosis infection. 34 
Diminished Th17 responses in the lung of M. tuberculosis-infected TLR2 deficient animals 35 
were not caused by defective cell differentiation in the draining lymph node, but rather by 36 
reduced maintenance at the site of infection. Consistent with the decreased numbers of Th17 37 
cells in the lungs of infected TLR2 deficient animals, we observed reduced expression of 38 
CXCL9, CXCL10 and CXCL11, chemokines involved in recall responses to M. tuberculosis. 39 
Our data provides insights into the TLR2 role in infection with M. tuberculosis, with 40 
implications in pathophysiology of the disease and vaccine design. 41 
42 
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Introduction 43 
Phagocytic cells, such as macrophages, dendritic cells (DC) and neutrophils are amongst the 44 
first cells to sense the presence of Mycobacterium tuberculosis in the host. The recognition of 45 
M. tuberculosis by macrophages and DC involves several pattern recognition receptors 46 
(PRRs), such as toll-like receptors (TLRs) (1,2), DC-SIGN (3) and Dectin-1 (4). TLR2, 4 and 47 
9 have all been shown to mediate the in vitro recognition of M. tuberculosis and the cytokine 48 
response of macrophages or DC to this pathogen is lower in the absence of these TLRs, 49 
particularly of TLR2 (5-12). As for the role of TLRs in the outcome of the infection by 50 
mycobacteria, mouse models of MyD88 deficiency showed that these animals are highly 51 
susceptible to experimental infections with M. tuberculosis (13-15) or with M. avium (16), 52 
succumbing very early upon infection. In contrast, in experimental infections with low doses 53 
of M. tuberculosis inocula TLR2 deficient (-/-) mice behave similarly to wild-type ones in 54 
terms of bacterial burden (7,10,12,17,18), although a defective granuloma formation was 55 
observed (7,10,17,18). When high doses of pathogen were used (7,18) or when the TLR2 56 
deficiency was combined with TLR9 deficiency (10), a more pronounced role for TLR2 in the 57 
development of a protective immune response to M. tuberculosis was uncovered. In humans, 58 
several reports have linked the existence of polymorphisms in TLR2 or TLR2-signaling 59 
molecules with susceptibility to M. tuberculosis (19-24) and M. leprae (25). However, in 60 
some populations, TLR2 polymorphisms do not associate with increased risk of tuberculosis 61 
(26). In another study, a variant of the TLR signalling adaptor protein Mal, showing an 62 
attenuated TLR2 signal transduction, was found to be protective against tuberculosis (27). 63 
Therefore, the association of TLR2 polymorphisms with susceptibility to tuberculosis or 64 
severity of disease remains controversial and appears to greatly depend on the genetics of the 65 
host/ bacteria interplay (28).  66 
 67 
Teixeira-Coelho et al.  - 4 - 
T cell responses, in particular by IFN--producing CD4+ T helper 1 (Th1) cells, are of 68 
extreme importance in controlling infections by M. tuberculosis both in mice and men 69 
(29,30). TLR9, but not TLR2, was shown to participate in the generation of Th1 cell 70 
responses in M. tuberculosis-infected mice, as in its absence less IFN--producing CD4+ T 71 
cells were observed (10). In contrast, a more recent study showed unaffected development of 72 
Th1 cell responses in the absence of the master signalling adaptor myeloid differentiation 73 
factor 88 (MyD88) or in the combined absence of TLR2/TLR4/TLR9 (12). In addition to 74 
IFN--producing T cells, IL-17-producing T cells, both  T cells (31-33) and Th17 cells (34-75 
36), have been observed during mycobacterial infections. Although IL-17 appears to have a 76 
limited role in the host defence against this pathogen during primary aerogenic infection (37-77 
39), IL-17A deficiency impacts both granuloma formation and bacterial burden (33). During 78 
vaccination against M. tuberculosis, Th17 cells were described to be protective by 79 
accelerating the recruitment of Th1 cells to the site of infection (40). Furthermore, deregulated 80 
production of IL-17, due to repeated exposure to mycobacterial antigen, has been recently 81 
shown to associate with extensive lung pathology (41). In humans, an increased frequency of 82 
Th17 cells was associated with latency (42), whereas, in another study, reduced Th17 cells 83 
were associated with more severe disease (43). Thus, the relative contribution of Th17 cells 84 
remains to be elucidated in human M. tuberculosis infection and in animal models.  85 
 86 
The recognition mechanisms and signals that lead to IL-17 production by  T cells or to 87 
Th17 cell differentiation during infection by M. tuberculosis remain elusive. Martin et al. (44) 88 
reported that TLR2-mediated recognition of inactivated M. tuberculosis enhances IL-17 89 
production by  T cells. A role for TLR9 in regulating Mycobacterium bovis BCG-elicited 90 
immune responses in mice, through the expression of delta-like 4 Notch ligand, was reported, 91 
with lower Th17 responses observed in the absence of TLR9 (45). Further understanding 92 
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these signals is important considering the role of IL-17 in vaccination, protection and 93 
pathology during mycobacterial infections. To address this issue, we investigated the role of 94 
TLR2 in the development of Th17 cell responses to M. tuberculosis. We found that TLR2 95 
deficiency strongly impacts p19 (IL-23) expression during M. tuberculosis infection. As a 96 
result, the absence of TLR2 compromised the maintenance of M. tuberculosis-specific Th17 97 
cells at the site of infection. Interestingly, the differentiation of Th17 cell in the draining 98 
lymph nodes (LN) of infected mice was not affected by the absence of TLR2. Clarifying the 99 
molecular events determining the regulation of IL-17 production by TLR2 during 100 
mycobacterial infections may provide new hints for the modulation of vaccination, protective 101 
responses and pathology. 102 
103 
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Methods 104 
Bacteria  105 
H37Rv strain of M. tuberculosis was grown in Proskauer Beck medium containing 0.05% 106 
Tween 80 to mid-log phase and frozen in 1ml aliquots at –80°C. Inactivated H37Ra strain of 107 
M. tuberculosis was purchased from Difco Laboratories. 108 
 109 
Animals and experimental infection 110 
Eight to 12-week-old female C57BL/6 mice, obtained from Charles River (Barcelona, Spain), 111 
C57BL/6 OT-II/rag1-/- (OT-II) TCR transgenic, obtained from the National Institute for 112 
Medical Research, or TLR2-/- mice, maintained at ICVS, were used. Mice were anesthetized 113 
with Ketamine/Medetomidine and infected intra-nasally with M. tuberculosis H37Rv 114 
resulting in a dose of approximately 100-200 colony forming units (CFUs) delivered into the 115 
lungs. All mouse protocols were performed according to the European Union Directive 116 
86/609/EEC, and previously approved by the national authority Direcção Geral de 117 
Veterinária.  118 
 119 
Bacterial load determination 120 
Groups of 5-7 infected wild-type or TLR2-/- mice were killed by CO2 asphyxiation at several 121 
time points post M. tuberculosis infection, the lungs were aseptically excised and 122 
homogenized in phosphate-buffered saline (PBS). Serial dilutions of the lung homogenate 123 
were plated on nutrient 7H11 agar. CFUs were counted after 3 weeks of incubation at 37°C. 124 
 125 
Cell preparation and culture 126 
Lungs and mediastinal LN of infected animals were aseptically removed and cell suspensions 127 
were prepared as described previously (40). Lung and mediastinal LN cells were then used for 128 
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ELISPOT, RNA analysis and flow cytometric analysis of CD4 or of GR1, as described before 129 
(34,40). 130 
 131 
Quantitative Real Time-PCR analysis 132 
Total RNA from infected and non-infected lungs and mediastinal LN was extracted with 133 
TRIzol
®
 Reagent (Invitrogen, San Diego, CA) according to the manufacturer’s instructions. 134 
cDNA was synthesized and analyzed by real-time PCR as described previously (46). Target 135 
gene mRNA expression was quantified using SYBR green (Qiagen) and specific 136 
oligonucleotides (Supplementary Table 1) and normalized to the ubiquitin mRNA levels or 137 
using specific primer-probes (ABI) (Supplementary Table 1) and the LightCycler-FastStart 138 
DNA Master Hybridization (Roche) and normalized to the HPRT mRNA levels. 139 
 140 
Histological and Morphometric analysis.  141 
Caudal lobes of lungs from wild-type or TLR2-/- infected mice were inflated with 3.8% 142 
phosphate-buffered formalin, fixed for 1 week and embedded in paraffin. Sections of 4 μm 143 
thickness were stained with hematoxylin and eosin (HE) for the inflammatory index score or 144 
used to detect iNOS by immunofluorescence with a goat anti-mouse antibody (M-19G from 145 
Santa Cruz biotechnology) and detected with Alexa Fluor 568-conjugated polyclonal rabbit 146 
anti-goat (Invitrogen). DAPI (4´,6-diamino-2-phenylindole hydrochloride) was used to 147 
counterstain tissues and to detect nuclei. All H&E sections were blindly analyzed by an 148 
independent pathologist and individually scored for inflammation according to the following 149 
scale: 0, absent; 1, mild; 2, abundant; 3, severe. Similarly, a score was attributed to the 150 
number of iNOS foci: 0, No foci; 1, 0-10 foci; 2, 10-20 foci; 3, 20-30 foci; 4, >30 foci. 151 
 152 
 153 
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Statistics 154 
Data are expressed as Mean ± SEM, and the significance of differences between two means 155 
was assessed with two-tailed Student t-test. Differences were considered statistically 156 
significant if p ≤ 0.05. 157 
158 
Teixeira-Coelho et al.  - 9 - 
Results 159 
TLR2 regulates Th17 cell responses to infection with M. tuberculosis 160 
To clarify the molecular signals determining the establishment of M. tuberculosis-specific 161 
Th17 cell responses, wild-type or TLR2-/- animals were infected intra-nasally with a low dose 162 
of M. tuberculosis. The profile of Th cell responses was analysed by ELISPOT in the lungs of 163 
infected animals 21, 54 or 215 days post-infection. In line with previous reports 164 
(7,10,12,17,18), the bacterial burden in the lung of wild-type or TLR2-/- animals was similar 165 
(Table 1). The number of Th17 cell responses, already seemingly reduced at 21 days post-166 
infection, was significantly diminished at days 54 and 215 post- M. tuberculosis infection in 167 
the absence of TLR2 (Fig. 1A). In contrast, the number of Th1 cells appeared to be unaffected 168 
by the absence of TLR2 until very late time points post-infection (Fig. 1B). We also followed 169 
the expression of IL-17A and IFN- in the lungs of infected animals by real-time PCR. The 170 
expression of IL-17 (Fig.1C), but not IFN- (data not shown), was highly affected by the 171 
absence of TLR2, being this effect more pronounced on day 54 post-infection. Consistent 172 
with the lower expression of IL-17, the transcription of chemokines known to be induced by 173 
IL-17 (40), namely CXCL9, CXCL10 and CXCL11 (Fig. 1D, 1E and 1F), was also 174 
diminished in the lung on day 54 post-infection. Our data thus suggest that TLR2 is an 175 
important upstream molecule in mediating Th17 cell responses to M. tuberculosis. 176 
 177 
M. tuberculosis induced p19 expression is mediated by TLR2 signalling 178 
Considering the importance of IL-23 for the establishment of Th17 cells, we investigated 179 
whether IL-23 expression was modulated by TLR2 recognition of M. tuberculosis. We 180 
measured the expression of p40 and p19, the monomers that form bioactive IL-23, in the 181 
lungs of wild-type or TLR2-/- mice during the course of infection. We observed that the 182 
induction of p19 expression observed in wild-type mice did not occur in the lungs of M. 183 
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tuberculosis infected TLR2-/- mice (Fig. 2A). In addition, the overall transcription of p40 in 184 
the lungs of infected animals was lower in the absence of TLR2 (Fig. 2B), whereas the 185 
expression of p35, which together with p40 forms IL-12, was not significantly affected in the 186 
absence of TLR2 (Fig. 2C). The expression of IL-6 and IL-1β in the lungs of TLR2-/- infected 187 
animals was also significantly lower than in wild-type animals at early time points post-188 
infection (Fig. 2D and 2E). Of note, since only the cleaved IL-1β molecule is biologically 189 
active, the fact that its mRNA is downregulated in the absence of TLR2 should be interpreted 190 
with caution and only provides an indication that the amount of IL-1β may be decreased. Our 191 
data suggest that TLR2 is required for the induction of p19 and IL-1β expression, two key 192 
molecules for the establishment of appropriate M. tuberculosis-specific Th17 responses. 193 
 194 
TLR2 signalling during M. tuberculosis infection does not impact Th17 cell 195 
differentiation in the LN 196 
Taking into consideration that IL-23 is not involved in the initial steps of Th17 cell 197 
differentiation (47), we next investigated whether the differentiation of Th17 cells in the 198 
draining mediastinal LN during M. tuberculosis infection occurred normally in TLR2-/- mice. 199 
To address this issue, we started by comparing the total cell number (Fig. 3A) and the number 200 
of CD4
+
 T cells (Fig. 3B) in the mediastinal LN of wild-type and TLR2-/- mice infected with 201 
M. tuberculosis for 14 or 28 days and found no differences. We chose these early time points 202 
since Th cell differentiation upon M. tuberculosis infection has been described to start in the 203 
mediastinal LN at around day 14 post-infection (48,49). We next assessed by ELISPOT, the 204 
number of Th17 cells in the mediastinal LN of wild-type or TLR2-/- infected animals. As 205 
shown in Fig. 3C, the number of IL-17-producing T cells in the mediastinal LN of infected 206 
animals was similar in the presence or absence of TLR2. Consistent with unaffected initiation 207 
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of Th17 responses in TLR2-/- mice, the expression of IL-6, although barely detectable in 208 
infected mediastinal LN, was not decreased in the absence of TLR2 (data not shown).  209 
 210 
TLR2 deficiency transiently delays lung inflammation in response to M. tuberculosis 211 
infection 212 
Considering that both TLR2 and IL-17 have been implicated in the inflammatory response to 213 
M. tuberculosis, we questioned whether TLR2 deficiency impacts the kinetics of the lung 214 
inflammatory response following M. tuberculosis infection. We found that at day 54 post-215 
infection the lung inflammatory infiltration was reduced in TLR2-/- animals (Fig. 4A). 216 
However, at very late stages of infection the histological pattern observed was similar, 217 
independently on the presence or absence of TLR2 (Fig. 4A). Despite the lower amounts of 218 
IL-17 and the significantly lower inflammatory index, in TLR2-/- mice we did not observe a 219 
difference in the numbers of GR1
+
 cells (likely neutrophils) in the lungs of TLR2-/- animals 220 
(Fig. 4B), as measured by flow cytometry. We observed that the number of iNOS-expressing 221 
foci (Fig. 4C), as assessed by immunofluorescence, was diminished in M. tuberculosis-222 
infected TLR2-/- animals, 54 days post-infection. In line with the histological analysis, at late 223 
stages post-infection (215 days), both strains of animals showed similar iNOS expression 224 
(Fig. 4C). Our data thus show that TLR2 modulates the lung inflammatory response during 225 
M. tuberculosis infection. 226 
227 
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Discussion 228 
IL-17 has been recently reported as a key molecule for the development of mycobacteria 229 
granuloma (33) and lung pathology (41), in addition to its role on recall responses (40). In 230 
humans, altered Th17 cells have been associated with either latency or more severe disease 231 
(42,43). Thus, understanding the relative contribution of Th17 cells in human M. tuberculosis 232 
infection and in animal models is of major interest. Therefore, a better knowledge of the 233 
molecular signals needed for IL-17 expression, namely those involved in Th17 cell 234 
establishment, during M. tuberculosis infections is important. 235 
 236 
TLR2 has been positively implicated as a regulator of Th17 cells in Streptococcus 237 
pneumoniae (50) or Candida albicans (51) infections, as well as in inflamed skin (52) and 238 
EAE (53), indicating that TLR2 is a key molecule on the induction of IL-17 mediated immune 239 
response. However, in infections by Staphylococcus aureus (54) or by Paracoccidioides 240 
brasiliensis (55), TLR2 acts as a negative regulator of Th17 cells. We now report that TLR2 241 
signaling, although not required for the differentiation of M. tuberculosis-specific Th17 cells 242 
in the draining LN of infected animals, is of extreme importance for the induction of p19 (and 243 
thus of IL-23) and maintenance of Th17 cells at the site of infection. Our data are consistent 244 
with the well known role for IL-23 in the maintenance of Th17 cells (34,47,56), and in line 245 
with a previous report showing that mice lacking p19 produce significantly lower levels of IL-246 
17 in the lung during M. tuberculosis infection (39). 247 
 248 
In addition to inducing IL-23, we suggest that M. tuberculosis recognition by TLR2 may also 249 
be involved in up-regulating the expression of other factors that mediate Th17 cell responses. 250 
Consistently, in the absence of TLR2, we observed a decreased lung expression of IL-1β, 251 
another survival factor for Th17 cells (56,57). Furthermore, the expression of IL-6 in the lung 252 
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was also decreased in TLR2-/- infected mice, which can contribute via defective IL-6-trans-253 
signalling for defective Th17 cell expansion and maintenance (58). In agreement with lower 254 
local Th17 cell responses, we also found a decreased expression of CXCL9, CXCL10 and 255 
CXCL11 in the lungs of M. tuberculosis-infected TLR2-/- animals. These IL-17-induced 256 
chemokines were reported to participate in the recruitment, during recall responses, of CD4
+
 257 
T cells producing IFN-, which ultimately restrict bacterial growth (40). Taking into 258 
consideration that M.tuberculosis-specific Th17 cells, following vaccination, are mainly 259 
resident in the lung and contribute to a faster recruitment of protective Th1 cells (40), signals 260 
that sustain Th17 responses, including as we now show those mediated by TLR2, may be of 261 
major interest to modulate the local immune response and potentiate vaccine efficacy. 262 
 263 
Our study, placing TLR2 signaling as an important molecular mediator of effective Th17 cell 264 
responses during M. tuberculosis infections, unveils a potential role for TLR2 signals during 265 
recall responses, such as during vaccination (an hypothesis that we are currently addressing) 266 
or re-infection. This is of particular importance as, in humans, polymorphisms in the TLR2 267 
gene have been associated to increased severity of tuberculosis (19-24). Since most of the 268 
human studies have been performed in endemic areas, it is tempting to speculate that the 269 
problems faced by these individuals to control tuberculosis might be associated with 270 
impairment in mounting appropriate recall responses. 271 
 272 
Previous studies suggested that mice lacking TLR2 suffered an exacerbated pathology in the 273 
lungs upon infection with M. tuberculosis, which was related to defective granuloma 274 
formation (10,17,18). In our study, we observed a transient delay in the lung inflammatory 275 
response of TLR2-/- mice, as assessed by histological analysis and quantification of iNOS-276 
expressing foci. At late times post-infection, however, wild-type and TLR2-/- animals showed 277 
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similar patterns of lung and liver (data not shown) inflammation, suggesting that the observed 278 
defect is transient and can be compensated over-time. It is conceivable that, in situations 279 
where TLR2-/- mice are unable to compensate the delayed inflammatory response in the lung, 280 
as it is the case of infection with high doses of inoculum (7,18) or of combined TLR2/9 281 
deficiencies (10), the control of bacterial growth may be put at risk. 282 
 283 
Lung pathology during M. tuberculosis infection frequently associates with increased 284 
neutrophil influx and formation of pyogranuloma. TLR2-/- mice have been shown previously 285 
to have increased lung neutrophil influx (10,17,18). We did not observe a difference in the 286 
number of GR1
+
 cells (likely neutrophils) in the lungs of M. tuberculosis-infected TLR2-/- 287 
animals. This discrepancy could be due to the fact that different routes and doses of infection 288 
were used. Of note, in a model of M. avium intra-venous infection, TLR2-/- animals did not 289 
exhibit an enhanced influx of neutrophils into the liver (16). 290 
 291 
Understanding the molecular signals that dictate Th17 differentiation during infection gains a 292 
novel importance in light of the recent evidence for a role of IL-17 in determining protection 293 
versus pathology during infections by mycobacteria (33,41-43) Furthermore, considering the 294 
described role of Th17 cells in accelerating Th1 responses during secondary infections (40), 295 
and thus in increasing the efficacy of vaccination, TLR2 deficient signals, as our results now 296 
suggest, may compromise the efficiency of vaccination against tuberculosis and provide new 297 
targets for vaccine improvement. 298 
299 
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Abbreviations 300 
CFU, colony forming units; CXCL, CXC ligand; HE, hematoxylin and eosin; IFN, Interferon; 301 
IL, Interleukin; LN, lymph nodes; MyD88, myeloid differentiation factor 88; OVA 302 
ovalbumin; PRR, pattern recognition receptor; Th, T helper; TLR, Toll like receptor; -/-, 303 
deficient. 304 
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Table 1. Bacterial counts (Mean±SEM) in the lungs of wild-type or TLR2-/- mice infected 319 
with M. tuberculosis
a
. 320 
 Bacterial counts (log10CFU) 
 Wild-type TLR2-/- 
Day 1 2.28±0.05 2.10±0.11 
Day 50 5.17±0.42 4.71±0.15 
Day 215 5.33±0.30 4.69±0.28 
 321 
a At the indicated time points, lungs from 5-6 infected mice were harvested and homogenized, diluted and then 322 
plated to determine the number of mycobacterial colony forming units per organ. Means were determined to be 323 
not statistically different as described in the methods. 324 
325 
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Figure legends 532 
Figure 1: Lung Th17 cell responses during infections by M. tuberculosis are 533 
compromised in the absence of TLR2. 534 
Wild-type or TLR2-/- mice were infected intra-nasally and, at the indicated time points, lung 535 
cell suspensions were prepared, isolated cells stimulated for 24h with ESAT-6 peptide 536 
presented by total spleen irradiated antigen-presenting cells and IL-17 (A) or IFN- (B) 537 
production assessed by ELISPOT. In parallel, RNA was extracted from the lung tissue and the 538 
expression of IL-17 (C), CXCL9 (D), CXCL10 (E) or CXCL11 (F) analyzed by quantitative 539 
real-time PCR and normalized to the expression of ubiquitin (C) or HPRT (D-F). Data 540 
represented for day 0 correspond to uninfected animals. Data points show the Mean  SEM 541 
value for 5-6 mice per group and the significance was determined by the Student´s t test 542 
(*p<0.05; **p<0.01). The data are representative of two independent experiments. 543 
 544 
Figure 2: TLR2 regulates the expression of p19 in the lung, during M. tuberculosis 545 
infections. 546 
Wild-type or TLR2-/- mice were infected as before and at the indicated time points, lung 547 
tissue was obtained, RNA extracted and p19 (A), p40 (B), p35 (C), IL-6 (D) and IL-1β (E) 548 
expression measured by real-time PCR and normalized to ubiquitin. Data points show the 549 
Mean  SEM value for 5-6 mice per group and the significance was determined by the 550 
Student´s t test (*p<0.05). Data represented for day 0 correspond to uninfected animals. The 551 
data are representative of two independent experiments. 552 
 553 
554 
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Figure 3: Absence of TLR2 does not affect the frequency of Th17 cells in the LN of M. 555 
tuberculosis-infected animals. 556 
Wild-type or TLR2-/- mice were infected as in Fig.1 and, on days 14 and 28 post-infection, 557 
mediastinal LN were harvested, cell suspensions obtained and counted for total cell number 558 
determination (A) or stained with anti-CD4-APC specific antibodies for CD4
+
 cell number 559 
determination by flow cytometry (B). Cells were also stimulated as indicated in Fig. 1 for the 560 
assessment of IL-17 production by ELISPOT (C). Data points show the Mean  SEM value 561 
for 5-6 mice per group and the significance was determined by the Student´s t test. The data 562 
are representative of two independent experiments. 563 
 564 
Figure 4: TLR2 regulates lung inflammation during M. tuberculosis infections. 565 
Wild-type or TLR2-/- mice were infected as before and, at the indicated time points post-566 
infection, sections were prepared from formalin-fixed lungs. The degree of inflammation in 567 
the lungs of multiple mice was quantified in a blinded manner using a scale (the inflammatory 568 
indexes were: 0, absent; 1, mild; 2, abundant; 3, severe inflammation). The values from 569 
independent lungs were then combined to give a mean±SD (A). At the indicated time points, 570 
lung cell suspensions were prepared and analyzed by flow cytometry for surface expression of 571 
GR1 (B). The number of iNOS-expressing foci in the lung tissue was determined by 572 
immunofluorescence, quantified and scored for each animal within the group (5-6 animals). 573 
iNOS foci scores were: No foci=0; 0-10=1; 10-20=2; 20-30=3; >30=4 (C). Significance was 574 
determined by the Student´s t test (*p<0.05). The data are representative of two independent 575 
experiments. 576 
 577 
 578 
579 
Teixeira-Coelho et al.  - 30 - 
 580 
581 
Teixeira-Coelho et al.  - 31 - 
 582 
583 
Teixeira-Coelho et al.  - 32 - 
584 
Teixeira-Coelho et al.  - 33 - 
 585 
586 
Teixeira-Coelho et al.  - 34 - 
Supplementary Table I: Sequences of the specific oligonucleotides and references of the primer-probe sets 587 
used for mRNA quantification by real-time PCR. 588 
Gene Forward oligonucleotide (5’3’) Reverse oligonucleotide (5’3’) 
IL-12p40 CAA ATT ACT CCG GAC GGT TC AGA GAC GCC ATT CCA CAT GTC 
IL-23p19 CGT ATC CAG TGT GAA GAT GGT TGT GCT CCC CTT TGA AGA TGT CAG A 
IL-12p35 TGC TGG TGG CCA TCG AT GCA GAG TCT CGC CAT TAT GAT T 
IL-17 CTC AGA CTA CCT CAA CCG TTC CA TTC CCT CCG CAT TGA CAC A 
IFN-γ CAA CAG CAA GGC GAA AAA GG GGA CCA CTC GGA TGA GCT CA 
IL-6   ACA CAT GTT CTC TGG GAA ATC GT AAG TGC ATC ATC GTT GTT CAT ACA 
IL-1β ACC TTC CAG GAT GAG GAC ATG A AAC GTC ACA CAC CAG CAG GTT A 
Ubiquitin TGG CTA TTA ATT ATT CGG TCT GCA T GCA AGT GGC TAG AGT GCA GAG TAA 
 
Gene Primer-probe set reference (Applied Biosystems) 
CXCL9 Mm00434946_m1 
CXCL10 Mm 99999072_m1 
CXCL11 Mm00444662_m1 
HPRT Mm00446968_m1 
 589 
